BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 2560186)

  • 1. [The function of the hypothalamo-hypophyseal-adrenal system in Itsenko-Cushing syndrome].
    Luchitskiĭ EV; Valueva GV; Markov VV; Slavnov VN; Rybakov SI
    Probl Endokrinol (Mosk); 1989; 35(6):38-42. PubMed ID: 2560186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interrelation of disorders in gonadotropin and prolactin secretion and the activity of the hypothalamo-hypophyseal-adrenal system in Itsenko-Cushing disease].
    Manusharova RA; Cheban AK; Komissarenko IV; Slavnov VN; Veĭnberg EG
    Probl Endokrinol (Mosk); 1984; 30(4):31-5. PubMed ID: 6089167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The secretion of alpha-melanotropin in diseases of the hypothalamus-hypophysis-adrenal cortex system].
    Slavnov VN; Luchitskiĭ EV; Oleĭnik VA; Komissarenko IB
    Probl Endokrinol (Mosk); 1990; 36(2):40-3. PubMed ID: 2163527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Various mechanisms of disorders of the hypothalamo-hypophyseal-adrenal system in Cushing's syndrome].
    Slavnov VN; Luchitskiĭ EV; Komissarenko IV; Cheban AK
    Probl Endokrinol (Mosk); 1978; 24(1):30-5. PubMed ID: 204919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Changes in the secretion of the hormones of the hypothalamo-hypophyseo-adrenal system in Itsenko-Cushing disease under the influence of insulin-induced hypoglycemia and thyroliberin].
    Slavnov VN; Luchitskiĭ EV
    Vrach Delo; 1990 Mar; (3):72-5. PubMed ID: 2164280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence of a circadian rhythmicity of glucocorticoid secretion in a patient with Cushing's syndrome: study before and after unilateral adrenalectomy.
    Ambrosi B; Riva E; Faglia G
    J Endocrinol Invest; 1985 Aug; 8(4):363-7. PubMed ID: 2999211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some mechanisms of hypothalamo-hypophysio-adrenal disturbances in Itsenko-Cushing's disease.
    Slavnov VN; Luchitskii EV; Komissarenko IV; Cheban AK
    Neurosci Behav Physiol; 1980; 10(2):159-63. PubMed ID: 6248814
    [No Abstract]   [Full Text] [Related]  

  • 8. Radioimmunoassayable ACTH in dexamethasone nonsuppressible Cushing's syndrome.
    Rayyis SS; Bethune JE
    J Clin Endocrinol Metab; 1969 Sep; 29(9):1231-7. PubMed ID: 4309156
    [No Abstract]   [Full Text] [Related]  

  • 9. [Blood ACTH levels in Itsenko-Cushing's disease].
    Makarovskai EE; Marova EI
    Probl Endokrinol (Mosk); 1971; 17(3):38-41. PubMed ID: 4333087
    [No Abstract]   [Full Text] [Related]  

  • 10. The recovery of the hypothalamo-pituitary-adrenal axis after transsphenoidal operation in three patients with Cushing's disease. The effect of prior external pituitary irradiation.
    Lamberts SW; Klijn GM; de Jong JG; Birkenhäger JC
    Acta Endocrinol (Copenh); 1981 Dec; 98(4):580-5. PubMed ID: 6272518
    [No Abstract]   [Full Text] [Related]  

  • 11. Life events, cortisol, and depression.
    Sher L
    Psychother Psychosom; 2003; 72(5):289-90. PubMed ID: 12920334
    [No Abstract]   [Full Text] [Related]  

  • 12. Lysine vasopressin stimulation of cortisol secretion in patients with adrenocorticotropin-independent macronodular adrenal hyperplasia.
    Horiba N; Suda T; Aiba M; Naruse M; Nomura K; Imamura M; Demura H
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2336-41. PubMed ID: 7629226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A fundamental defect of adrenocortical control in Cushing's disease.
    James VH; Landon J; Wynn V; Greenwood FC
    J Endocrinol; 1968 Jan; 40(1):15-28. PubMed ID: 4294723
    [No Abstract]   [Full Text] [Related]  

  • 14. [The effect of GABA-ergic preparations on the function of the hypothalamo-hypophyseal-adrenal system in patients with Itsenko-Cushing disease].
    Mishunina TM; Kononenko VIa; Komissarenko IV; Luchitskiĭ EV
    Probl Endokrinol (Mosk); 1991; 37(4):28-31. PubMed ID: 1664951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The hypothalamus-hypophysis-adrenal system in patients with lactorrhea-amenorrhea syndrome].
    Oleĭnik VA; Luchitskiĭ EV; Valueva GV
    Probl Endokrinol (Mosk); 1989; 35(5):14-8. PubMed ID: 2555814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of serum macrophage migration inhibitory factor levels to stimulation or suppression of the hypothalamo-pituitary-adrenal axis in normal subjects and patients with Cushing's disease.
    Isidori AM; Kaltsas GA; Korbonits M; Pyle M; Gueorguiev M; Meinhardt A; Metz C; Petrovsky N; Popovic V; Bucala R; Grossman AB
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1834-40. PubMed ID: 11932327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypothalamo-pituitary-adrenal cortex system and the glucocorticoid kinetics in Cushing's syndrome treated with chlodithane and large doses of reserpine].
    Slavnov VN; Luchitskiĭ EV; Komissarenko IV; Markov VV; Cheban AK
    Ter Arkh; 1980; 52(7):124-8. PubMed ID: 6105729
    [No Abstract]   [Full Text] [Related]  

  • 18. Human studies on hypothalamo-pituitary-adrenal (HPA) axis.
    Liyanarachchi K; Ross R; Debono M
    Best Pract Res Clin Endocrinol Metab; 2017 Oct; 31(5):459-473. PubMed ID: 29223281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disorders of the hypothalamic-pituitary-adrenal axis.
    Wand GS; Ney RL
    Clin Endocrinol Metab; 1985 Feb; 14(1):33-53. PubMed ID: 2990779
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical significance of the diagnostic use and assay of corticotropin-releasing hormone in the physiopathologic state of the hypothalamo-pituitary-adrenal axis].
    Nishikawa T; Yoshida A; Mikami K; Tamura Y; Yoshida S
    Nihon Rinsho; 1990 Feb; 48 Suppl():182-4. PubMed ID: 2162415
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.